<VariationArchive VariationID="1072690" VariationName="NC_000005.9:g.(?_149775825)_(149778631_?)del" VariationType="Deletion" Accession="VCV001072690" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057145" VariationID="1072690">
      <GeneList>
        <Gene Symbol="TCOF1" FullName="treacle ribosome biogenesis factor 1" GeneID="6949" HGNC_ID="HGNC:11654" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q32-33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="150357697" stop="150400293" display_start="150357697" display_stop="150400293" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="149737201" stop="149779870" display_start="149737201" display_stop="149779870" Strand="+" />
          </Location>
          <OMIM>606847</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TCOF1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TCOF1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.9:g.(?_149775825)_(149778631_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="149775825" innerStop="149778631" display_start="149775825" display_stop="149778631" variantLength="2807" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_149775825)_(149778631_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_149775825)_(149778631_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.9:g.(?_149775825)_(149778631_?)del AND Treacher Collins syndrome 1" Accession="RCV001385460" Version="8">
        <ClassifiedConditionList TraitSetID="7950">
          <ClassifiedCondition DB="MedGen" ID="CN315775">Treacher Collins syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-07-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9736782</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9811939</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7950" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16740" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Treacher Collins syndrome 1</ElementValue>
                <XRef ID="Treacher+Collins+syndrome/7175" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007944" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TCS</ElementValue>
                <XRef Type="MIM" ID="154500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MFD1</ElementValue>
                <XRef Type="MIM" ID="154500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TCS1</ElementValue>
                <XRef Type="MIM" ID="154500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.</Attribute>
                <XRef ID="NBK1532" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301704</ID>
                <ID Source="BookShelf">NBK1532</ID>
              </Citation>
              <XRef ID="861" DB="Orphanet" />
              <XRef ID="CN315775" DB="MedGen" />
              <XRef ID="MONDO:0007944" DB="MONDO" />
              <XRef Type="MIM" ID="154500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3110959" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_001135243.1_5_Deletion (exons 24-26)|MedGen:CN119605" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585313" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9811939</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9736782</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant is a gross deletion of the genomic region encompassing exons 24-26 of the TCOF1 gene. The 5' boundary is likely confined to intron 23. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TCOF1 protein. This variant has been observed in an individual affected with Treacher Collins syndrome (Invitae). Experimental studies have shown that the final 160-190 amino acids of the TCOF1 protein contain nuclear and nucleolar localization signals. Deletion of these residues leads to mislocalization of the protein in cell culture-based assays (PMID: 9811939, 9736782). Similar deletions of this region have been reported in patients affected with Treacher Collins syndrome (PMID:¬†22317976).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TCOF1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_149775825)_(149778631_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN119605" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110959" TraitType="Disease" MappingType="XRef" MappingValue="CN119605" MappingRef="MedGen">
        <MedGen CUI="CN315775" Name="Treacher Collins syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

